¹Ýº¹ÀûÀÎ ¸ð¼¼±â°üÁö¿°, °ú¹ÝÀÀ ±â°üÁö¿°À» º¸ÀÎ ¿µÀ¯¾ÆÀÇ ÀÓ»ó¾ç»ó, Ä¡·á¿Í ÀÚ¿¬°æ°ú
Clinical Manifestations, Management, and Natural Course of Infants with Recurrent Bronchiolitis or Reactive Airways Disease
¼Ò¾Æ°¨¿° 2014³â 21±Ç 1È£ p.37 ~ p.42
¹ÚÇöÁø(Park Hyoun-Jin) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±èÁÖÇö(Kim Joo-Hyun) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÀüÀ±È«(Chun Yoon-Hong) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
À̼ö¿µ(Lee Soo-Young) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±è»ó¿ë(Kim Sang-Yong) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
°ÁøÇÑ(Kang Jin-Han) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Abstract
Purpose: The purpose of this study was to investigate the clinical manifestations and 5-year natural course of recurrent bronchiolitis or reactive airways disease (RAD) in infants.
Methods: We reviewed the medical records of infants with recurrent bronchiolitis from January 2007 to December 2007 at The Catholic University of Korea St. Mary¡¯s Hospital in Incheon, South Korea. Additionally, we telephoned their parents to confirm their present medical statuses.
Results: Sixty-three subjects with recurrent bronchiolitis were identified. The mean age at admission was 8.1 months and the number of males was 44 (69.8%). Of the 63 infants with recurrent bronchiolitis, inhaled corticosteroids, bronchodilators, and antibiotics were given to 62 (98.4%), 53 (84.1%), and 40 (63.5%), respectively. Among the total 63 subjects, we were able to contact the parents of 45 children by telephone. None of these children had been hospitalized during the previous one year period due to respiratory infections or for other medical reasons. Of the 45 subjects we were able to contact, 38 (84.4%) had not experienced any further respiratory difficulties at all. Five (11.1%) had been diagnosed with allergic rhinitis while two (4.4%) were being managed for asthma.
Conclusion: Most children who presented with recurrent episodes of bronchiolitis in infancy did not show any further respiratory difficulties after five years of age.
Å°¿öµå
Bronchiolitis, Infant, Follow-Up Studies
KMID :
0605820140210010037
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)